Overview: "Stay current with this mid-year clinical update featuring the June 2025 FDA approval of lenacapavir for HIV pre-exposure prophylaxis (PrEP). This downloadable job aid provides a concise clinical snapshot of the medication: including key considerations for administration, safety, and patient adherence. Whether you have already completed the HIVPCP Certification Program or are just starting, this tool is designed to equip you with the essential information to incorporate this new PrEP option into informed clinical decision-making."